Non-alcoholic fatty liver disease predicts development of metabolic comorbidities in HIV-infected patients
- Krahn, T
- Martel, M
- Sapir-Pichhadze, R
- Kronfli, N
- J, Falutz
- G, Guaraldi
- B, Lebouche
- Klein, M B
- Wong, P
- Deschenes, M
- Ghali, P
- Sebastiani, G
DOIAbstract
Cardiovascular and liver disease are main contributors to mortality in people with HIV (PWH). In HIV-uninfected patients, non-alcoholic fatty liver disease (NAFLD) is associated with incident metabolic complications. We investigated the effect of NAFLD on development of metabolic comorbidities in PWH
Add to ORKG